Viridian Therapeutics Ownership 2024 | Who Owns Viridian Therapeutics Now?
Institutional Ownership
113.75%
Insider Ownership
0.01%
Retail Ownership
-13.75%
Institutional Holders
146.00
Viridian Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 15.67% | 0.01% | 9,573,348 | 158,213 | 1.68% | 124,549,258 | Jun 30, 2024 |
| BLACKROCK INC. | 7.81% | 0.00% | 4,773,622 | 960,992 | 25.21% | 62,104,822 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 6.42% | 1.52% | 3,923,849 | 467,796 | 13.54% | 51,049,275 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.35% | 3.22% | 3,882,671 | - | - | 50,513,550 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.48% | 0.00% | 3,345,731 | 111,452 | 3.45% | 43,527,961 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 5.41% | 0.82% | 3,307,945 | 615,531 | 22.86% | 43,036,364 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.74% | 1.44% | 2,896,349 | -2,135,071 | -42.43% | 37,681,500 | Jun 30, 2024 |
| STATE STREET CORP | 4.54% | 0.00% | 2,772,379 | -1,716,236 | -38.24% | 36,068,651,000 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.14% | 2.25% | 2,528,032 | 593,379 | 30.67% | 32,889,696 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.27% | 0.57% | 2,000,000 | 900,000 | 81.82% | 9,760,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 3.27% | 0.01% | 1,998,192 | 275,373 | 15.98% | 25,996,478 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 3.02% | 2.71% | 1,845,813 | - | - | 24,014,027 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 2.86% | 1.76% | 1,750,000 | 1,616,123 | 1207.17% | 22,767,500 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.75% | 2.02% | 1,678,207 | - | - | 21,833,473 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.67% | 0.50% | 1,631,828 | -2,025,271 | -55.38% | 21,230,082 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 1,411,360 | 247,088 | 21.22% | 18,364,886 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.28% | 1.85% | 1,392,925 | 700,000 | 101.02% | 18,121,954 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.67% | 0.02% | 1,022,104 | -73,337 | -6.69% | 13,297,573 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.64% | 0.00% | 999,941 | 456,801 | 84.10% | 13,009,233 | Jun 30, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.55% | 0.99% | 948,130 | - | - | 12,335,171 | Jun 30, 2024 |
Viridian Therapeutics's largest institutional shareholder is FMR LLC, holding 15.67% of the company's total share outstanding, currently valued at $124.55M. The top 10 institutional shareholders own together 63.84% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VR ADVISER, LLC | 6.35% | 3.22% | 3,882,671 | - | - | 50,513,550 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.49% | 3.00% | 300,000 | - | - | 3,903,000 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 3.02% | 2.71% | 1,845,813 | - | - | 24,014,027 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.96% | 2.39% | 587,708 | -37,292 | -5.97% | 7,646,081 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.14% | 2.25% | 2,528,032 | 593,379 | 30.67% | 32,889,696 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.33% | 2.19% | 199,433 | - | - | 2,594,623 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.21% | 2.14% | 736,595 | - | - | 9,583,101 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.75% | 2.02% | 1,678,207 | - | - | 21,833,473 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.28% | 1.85% | 1,392,925 | 700,000 | 101.02% | 18,121,954 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 2.86% | 1.76% | 1,750,000 | 1,616,123 | 1207.17% | 22,767,500 | Jun 30, 2024 |
| KOPP FAMILY OFFICE, LLC | 0.34% | 1.66% | 205,737 | 97 | 0.05% | 2,677,000 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 6.42% | 1.52% | 3,923,849 | 467,796 | 13.54% | 51,049,275 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.74% | 1.44% | 2,896,349 | -2,135,071 | -42.43% | 37,681,500 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.01% | 1.27% | 620,000 | - | - | 8,066,200 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.82% | 1.25% | 500,000 | -835,000 | -62.55% | 6,505,000 | Jun 30, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.55% | 0.99% | 948,130 | - | - | 12,335,171 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.32% | 0.94% | 198,484 | - | - | 2,582,277 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 5.41% | 0.82% | 3,307,945 | 615,531 | 22.86% | 43,036,364 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 0.63% | 2,789 | -176,111 | -98.44% | 3,628,489 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.27% | 0.57% | 2,000,000 | 900,000 | 81.82% | 9,760,000 | Jun 30, 2024 |
The largest Viridian Therapeutics shareholder by % of total assets is VR ADVISER, LLC. The company owns 3.88M shares of Viridian Therapeutics (VRDN), representing 3.22% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KYNAM CAPITAL MANAGEMENT, LP | 2.86% | 1.76% | 1,750,000 | 1,616,123 | 1207.17% | 22,767,500 | Jun 30, 2024 |
| BLACKROCK INC. | 7.81% | 0.00% | 4,773,622 | 960,992 | 25.21% | 62,104,822 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 3.27% | 0.57% | 2,000,000 | 900,000 | 81.82% | 9,760,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.28% | 1.85% | 1,392,925 | 700,000 | 101.02% | 18,121,954 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 5.41% | 0.82% | 3,307,945 | 615,531 | 22.86% | 43,036,364 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.14% | 2.25% | 2,528,032 | 593,379 | 30.67% | 32,889,696 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.23% | 0.06% | 749,804 | 469,804 | 167.79% | 9,754,495 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 6.42% | 1.52% | 3,923,849 | 467,796 | 13.54% | 51,049,275 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.64% | 0.00% | 999,941 | 456,801 | 84.10% | 13,009,233 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.93% | 0.51% | 567,487 | 425,412 | 299.43% | 7,383,006 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.70% | 0.01% | 430,596 | 424,960 | 7540.10% | 5,602,054 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 3.27% | 0.01% | 1,998,192 | 275,373 | 15.98% | 25,996,478 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 1,411,360 | 247,088 | 21.22% | 18,364,886 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.37% | 0.00% | 228,182 | 207,711 | 1014.66% | 2,968,648 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.69% | 0.01% | 419,820 | 192,966 | 85.06% | 5,461,858 | Jun 30, 2024 |
| FMR LLC | 15.67% | 0.01% | 9,573,348 | 158,213 | 1.68% | 124,549,258 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.25% | 0.23% | 150,000 | 150,000 | 100.00% | 1,951,500 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.23% | 0.00% | 142,936 | 115,980 | 430.26% | 1,859,597 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.48% | 0.00% | 3,345,731 | 111,452 | 3.45% | 43,527,961 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.18% | 0.00% | 107,580 | 97,510 | 968.32% | 1,399,616 | Jun 30, 2024 |
As of Jun 30 2024, Viridian Therapeutics's largest institutional buyer is KYNAM CAPITAL MANAGEMENT, LP. The company purchased 1.62M stocks of VRDN, valued at $22.77M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 4.74% | 1.44% | 2,896,349 | -2,135,071 | -42.43% | 37,681,500 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.67% | 0.50% | 1,631,828 | -2,025,271 | -55.38% | 21,230,082 | Jun 30, 2024 |
| STATE STREET CORP | 4.54% | 0.00% | 2,772,379 | -1,716,236 | -38.24% | 36,068,651,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.82% | 1.25% | 500,000 | -835,000 | -62.55% | 6,505,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.82% | 0.00% | 498,403 | -834,051 | -62.60% | 6,484,224 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | - | - | - | -614,010 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -278,638 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.34% | 0.00% | 210,677 | -265,056 | -55.72% | 2,740,907 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.24% | 0.01% | 144,975 | -263,912 | -64.54% | 1,886,125 | Jun 30, 2024 |
| MORGAN STANLEY | 0.52% | 0.00% | 320,570 | -241,971 | -43.01% | 4,170,620 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 0.63% | 2,789 | -176,111 | -98.44% | 3,628,489 | Jun 30, 2024 |
| UBS GROUP AG | 0.38% | 0.00% | 230,376 | -149,208 | -39.31% | 2,997,192 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.67% | 0.02% | 1,022,104 | -73,337 | -6.69% | 13,297,573 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -69,430 | -100.00% | - | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.61% | 0.03% | 373,462 | -65,305 | -14.88% | 4,933,433 | Jun 30, 2024 |
| BARCLAYS PLC | 0.10% | 0.00% | 58,847 | -65,301 | -52.60% | 765,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -45,000 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.66% | 0.05% | 400,915 | -38,007 | -8.66% | 5,215,904 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.96% | 2.39% | 587,708 | -37,292 | -5.97% | 7,646,081 | Jun 30, 2024 |
As of Jun 30 2024, Viridian Therapeutics's biggest institutional seller is PARADIGM BIOCAPITAL ADVISORS LP. The company sold -2.14M shares of VRDN, valued at $37.68M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TREXQUANT INVESTMENT LP | 0.07% | 0.01% | 41,824 | 41,824 | 100.00% | 544,130 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 33,664 | 33,664 | 100.00% | 437,969 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 31,490 | 31,490 | 100.00% | 408,429 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.05% | 0.00% | 30,800 | 30,800 | 100.00% | 400,708 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.05% | 0.00% | 29,370 | 29,370 | 100.00% | 382,000 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.05% | 0.00% | 28,720 | 28,720 | 100.00% | 373,647 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.05% | 0.04% | 28,682 | 28,682 | 100.00% | 373,153 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.04% | 0.01% | 26,500 | 26,500 | 100.00% | 344,765 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.04% | 0.01% | 22,444 | 22,444 | 100.00% | 291,996 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.03% | 0.00% | 21,016 | 21,016 | 100.00% | 273,418 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.03% | 0.00% | 20,985 | 20,985 | 100.00% | 273,015 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.03% | 0.04% | 18,897 | 18,897 | 100.00% | 245,850 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 18,800 | 18,800 | 100.00% | 244,588 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.03% | 0.09% | 15,709 | 15,709 | 100.00% | 204,374 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.03% | 13,794 | 13,794 | 100.00% | 179,460 | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.00% | 10,324 | 10,324 | 100.00% | 134,000 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.11% | 5,569 | 5,569 | 100.00% | 72,453 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.00% | - | 1,200 | 1,200 | 100.00% | 15,612 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 0.23% | 1,000 | 1,000 | 100.00% | 1,301,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | - | 126 | 126 | 100.00% | 1,640 | Jun 30, 2024 |
Viridian Therapeutics's largest new institutional shareholder by number of shares is TREXQUANT INVESTMENT LP, purchased 41.82K shares, valued at $544.13K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | - | - | - | -614,010 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -278,638 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -69,430 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -45,000 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -28,822 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -28,406 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -24,515 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -19,323 | -100.00% | - | Jun 30, 2024 |
| BELLEVUE GROUP AG | - | - | - | -19,100 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -3,600 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,632 | -100.00% | - | Jun 30, 2024 |
| ORION CAPITAL MANAGEMENT LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | - | -187 | -100.00% | - | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -66 | -100.00% | - | Jun 30, 2024 |
| FORTITUDE FAMILY OFFICE, LLC | - | - | - | -29 | -100.00% | - | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
Viridian Therapeutics's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.70M shares, valued at -, as of undefined.
Viridian Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 1.54% | 251,903 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.26% | 249,134 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.24% | 2,034,907 | 2,034,907 | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.07% | 180,000 | 25,800 | 16.73% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 27,741 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 401,927 | 401,927 | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 2,219,238 | 1,958,538 | 751.26% | Feb 29, 2024 |
| BlackRock Health Sciences Trust II | 0.03% | 82,037 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.03% | 957,805 | 11,781 | 1.25% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 64,831 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.03% | 567 | 97 | 20.64% | Dec 31, 2023 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 210,000 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,847,752 | 1,847,752 | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 87,183 | 9,672 | 12.48% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,177 | 696 | 10.74% | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 98,530 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 340,000 | 20,000 | 6.25% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,614,246 | -623,515 | -19.26% | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 38,694 | 652 | 1.71% | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 57,753 | -83,712 | -59.18% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 90,000 | 5,000 | 5.88% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 29,338 | - | - | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 12,116 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 699 | - | - | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 13,983 | -811 | -5.48% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 8,249 | 7,351 | 818.60% | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 37,620 | 6,772 | 21.95% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 4,243 | 671 | 18.78% | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 122,655 | 4,982 | 4.23% | Jan 31, 2024 |
| Weiss Strategic Interval Fund | 0.00% | 8,810 | 8,810 | - | Sep 30, 2022 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 528,009 | 136,270 | 34.79% | Feb 29, 2024 |
| CARILLON SERIES TRUST | 0.00% | 119,446 | -5,677 | -4.54% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,380 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,961 | 799 | 19.20% | Mar 31, 2024 |
| ProFunds | 0.00% | 21,146 | 9,436 | 80.58% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 120,815 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 194,422 | -11,510 | -5.59% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 21,856 | 5,966 | 37.55% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,803 | -2,746 | -7.51% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 190,900 | 190,900 | - | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 13,753 | -1,447 | -9.52% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 204,513 | 10,977 | 5.67% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,511 | - | - | Mar 28, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 32,590 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 645,483 | 599,370 | 1299.79% | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 3,610 | 400 | 12.46% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 142,070 | 26,436 | 22.86% | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 672,500 | 609,650 | 970.01% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,223 | -216 | -8.86% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 288,549 | 88,490 | 44.23% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,414 | 374 | 18.33% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 11,057 | 690 | 6.66% | Mar 31, 2024 |
| Global X Funds | 0.00% | 20,792 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,985 | -1,697 | -10.17% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,445 | -447 | -7.59% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 138,870 | 84,767 | 156.68% | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 3,430 | - | - | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 3,113 | 3,113 | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 19,800 | 5,700 | 40.43% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 33,602 | 20,486 | 156.19% | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 3,100 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 231 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,764 | 600 | 27.73% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 29,346 | 2,057 | 7.54% | Mar 28, 2024 |
| RBB FUND, INC. | 0.00% | 17,493 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 20,803 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 487,272 | 340,619 | 232.26% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 1,831,494 | 134,941 | 7.95% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 194,035 | 25,548 | 15.16% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 115,906 | 3,176 | 2.82% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 385 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,140 | 5,397 | 80.04% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 3,406,660 | 1,599,793 | 88.54% | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 42,218 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,845 | 5,845 | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 26,052 | 4,230 | 19.38% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 16,406 | 146 | 0.90% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,048 | 717 | 11.33% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,400 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 191 | - | - | Dec 31, 2023 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 5,088 | 5,088 | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 4,435 | -1,426 | -24.33% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 8,544 | - | - | Feb 29, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 7,718 | 7,718 | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 3,461 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,039 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 11,192 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 6,220 | 2,093 | 50.71% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,264 | 809 | 14.83% | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 1,106 | -728 | -39.69% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 2,800 | 1,700 | 154.55% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 25 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 16,116 | 1,951 | 13.77% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,634 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 35,700 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 14,661 | 5,217 | 55.24% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,843 | 43 | 0.90% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 764 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 35,261 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 17,498 | 1,503 | 9.40% | Mar 31, 2024 |
Viridian Therapeutics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 251.90K shares, compromising 1.54% of its total assets.
Viridian Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 146 | 2.10% |
| 31 Mar, 24 | 143 | 2.88% |
| 31 Dec, 23 | 139 | 10.32% |
| 30 Sep, 23 | 126 | -11.27% |
| 30 Jun, 23 | 142 | -2.07% |
| 31 Mar, 23 | 145 | 13.28% |
| 31 Dec, 22 | 128 | 18.52% |
| 30 Sep, 22 | 108 | 22.73% |
| 30 Jun, 22 | 88 | 15.79% |
| 31 Mar, 22 | 76 | 38.18% |
| 31 Dec, 21 | 55 | 30.95% |
| 30 Sep, 21 | 42 | 75.00% |
| 30 Jun, 21 | 24 | -17.24% |
| 31 Mar, 21 | 29 | 1350.00% |
| 31 Dec, 20 | 2 | - |
As of 30 Jun 24, 146 institutions are holding Viridian Therapeutics's shares, representing an increase of 2.10% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 69,497,343 | -1.95% |
| 31 Mar, 24 | 70,881,269 | 17.87% |
| 31 Dec, 23 | 60,136,748 | 19.81% |
| 30 Sep, 23 | 50,192,424 | 6.27% |
| 30 Jun, 23 | 47,229,086 | 9.72% |
| 31 Mar, 23 | 43,046,043 | 4.28% |
| 31 Dec, 22 | 41,277,869 | 8.78% |
| 30 Sep, 22 | 37,946,251 | 33.98% |
| 30 Jun, 22 | 28,322,239 | 13.52% |
| 31 Mar, 22 | 24,949,852 | 7.27% |
| 31 Dec, 21 | 23,259,955 | 71.03% |
| 30 Sep, 21 | 13,600,176 | 126.54% |
| 30 Jun, 21 | 6,003,456 | 8.30% |
| 31 Mar, 21 | 5,543,237 | 2320.63% |
| 31 Dec, 20 | 229,000 | - |
Viridian Therapeutics (VRDN) has 69.50M shares outstanding as of 30 Jun 24, down -1.95% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.75% | 0.85% |
| 31 Mar, 24 | 116.01% | 0.79% |
| 31 Dec, 23 | 121.04% | 0.92% |
| 30 Sep, 23 | 114.98% | 0.96% |
| 30 Jun, 23 | 109.19% | 1.05% |
| 31 Mar, 23 | 101.90% | 0.98% |
| 31 Dec, 22 | 101.82% | 0.81% |
| 30 Sep, 22 | 112.46% | 1.08% |
| 30 Jun, 22 | 102.02% | 1.12% |
| 31 Mar, 22 | 95.50% | 1.20% |
| 31 Dec, 21 | 89.03% | 3.29% |
| 30 Sep, 21 | 52.06% | 9.86% |
| 30 Jun, 21 | 22.98% | 5.10% |
| 31 Mar, 21 | 21.22% | 2761.70% |
| 31 Dec, 20 | 0.88% | - |
As of 30 Jun 24, Viridian Therapeutics is held by 113.75% institutional shareholders, representing a 0.85% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 89 | 2.30% |
| 31 Mar, 24 | 87 | 19.18% |
| 31 Dec, 23 | 73 | 5.80% |
| 30 Sep, 23 | 69 | -23.33% |
| 30 Jun, 23 | 90 | 7.14% |
| 31 Mar, 23 | 84 | - |
| 31 Dec, 22 | 84 | 3.70% |
| 30 Sep, 22 | 81 | 47.27% |
| 30 Jun, 22 | 55 | 19.57% |
| 31 Mar, 22 | 46 | 9.52% |
| 31 Dec, 21 | 42 | 20.00% |
| 30 Sep, 21 | 35 | 150.00% |
| 30 Jun, 21 | 14 | -48.15% |
| 31 Mar, 21 | 27 | 1250.00% |
| 31 Dec, 20 | 2 | - |
89 institutional shareholders have increased their position in VRDN stock as of 30 Jun 24 compared to 87 in the previous quarter (a 2.30% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | -12.12% |
| 31 Mar, 24 | 33 | -25.00% |
| 31 Dec, 23 | 44 | 25.71% |
| 30 Sep, 23 | 35 | 40.00% |
| 30 Jun, 23 | 25 | -32.43% |
| 31 Mar, 23 | 37 | 32.14% |
| 31 Dec, 22 | 28 | 86.67% |
| 30 Sep, 22 | 15 | -16.67% |
| 30 Jun, 22 | 18 | 12.50% |
| 31 Mar, 22 | 16 | 220.00% |
| 31 Dec, 21 | 5 | 66.67% |
| 30 Sep, 21 | 3 | -25.00% |
| 30 Jun, 21 | 4 | - |
| 31 Mar, 21 | - | - |
| 31 Dec, 20 | - | - |
29 institutional shareholders have reduced their position in VRDN stock as of 30 Jun 24 compared to 33 in the previous quarter (a -12.12% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 146 | 2.10% | 69,497,343 | -1.95% | 113.75% | 0.85% | 89 | 2.30% | 29 | -12.12% |
| 31 Mar, 24 | 143 | 2.88% | 70,881,269 | 17.87% | 116.01% | 0.79% | 87 | 19.18% | 33 | -25.00% |
| 31 Dec, 23 | 139 | 10.32% | 60,136,748 | 19.81% | 121.04% | 0.92% | 73 | 5.80% | 44 | 25.71% |
| 30 Sep, 23 | 126 | -11.27% | 50,192,424 | 6.27% | 114.98% | 0.96% | 69 | -23.33% | 35 | 40.00% |
| 30 Jun, 23 | 142 | -2.07% | 47,229,086 | 9.72% | 109.19% | 1.05% | 90 | 7.14% | 25 | -32.43% |
| 31 Mar, 23 | 145 | 13.28% | 43,046,043 | 4.28% | 101.90% | 0.98% | 84 | - | 37 | 32.14% |
| 31 Dec, 22 | 128 | 18.52% | 41,277,869 | 8.78% | 101.82% | 0.81% | 84 | 3.70% | 28 | 86.67% |
| 30 Sep, 22 | 108 | 22.73% | 37,946,251 | 33.98% | 112.46% | 1.08% | 81 | 47.27% | 15 | -16.67% |
| 30 Jun, 22 | 88 | 15.79% | 28,322,239 | 13.52% | 102.02% | 1.12% | 55 | 19.57% | 18 | 12.50% |
| 31 Mar, 22 | 76 | 38.18% | 24,949,852 | 7.27% | 95.50% | 1.20% | 46 | 9.52% | 16 | 220.00% |
| 31 Dec, 21 | 55 | 30.95% | 23,259,955 | 71.03% | 89.03% | 3.29% | 42 | 20.00% | 5 | 66.67% |
| 30 Sep, 21 | 42 | 75.00% | 13,600,176 | 126.54% | 52.06% | 9.86% | 35 | 150.00% | 3 | -25.00% |
| 30 Jun, 21 | 24 | -17.24% | 6,003,456 | 8.30% | 22.98% | 5.10% | 14 | -48.15% | 4 | - |
| 31 Mar, 21 | 29 | 1350.00% | 5,543,237 | 2320.63% | 21.22% | 2761.70% | 27 | 1250.00% | - | - |
| 31 Dec, 20 | 2 | - | 229,000 | - | 0.88% | - | 2 | - | - | - |
Viridian Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Viridian Therapeutics's stock was made by Fairmount Funds Management LLC on Apr 01 2024, selling 21,999 shares at - per share (valued at -). The last insider buy of VRDN was made by Fairmount Funds Management LLC on Jan 24 2024, buying 476,190 shares at $21.00 per share (worth $10.00M).
Viridian Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | - | - |
| Q1 2024 | 5 | 6 | 83.33% |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 10 | 10 | 100.00% |
| Q1 2023 | 14 | 13 | 107.69% |
| Q4 2022 | 7 | 11 | 63.64% |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 6 | 5 | 120.00% |
| Q1 2022 | 4 | 5 | 80.00% |
| Q4 2021 | 2 | 3 | 66.67% |
| Q3 2021 | 4 | 1 | 400.00% |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 9 | - | - |
| Q4 2020 | 14 | 4 | 350.00% |
| Q3 2020 | 2 | - | - |
| Q2 2020 | 6 | 1 | 600.00% |
| Q1 2020 | 4 | 1 | 400.00% |
| Q4 2019 | - | 2 | - |
| Q3 2019 | 1 | 1 | 100.00% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Viridian Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 1 | 5 | 20.00% |
| Q1 2023 | 1 | 6 | 16.67% |
| Q4 2022 | - | 4 | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 5 | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Viridian Therapeutics's stocks.
Viridian Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MRUS | Merus N.V. |
| BPMC | Blueprint Medicines Corporation |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| ACLX | Arcellx, Inc. |
| GPCR | Structure Therapeutics Inc. |
| ETNB | 89bio, Inc. |
| PCVX | Vaxcyte, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| CYTK | Cytokinetics, Incorporated |
| KURA | Kura Oncology, Inc. |
VRDN Ownership FAQ
Who Owns Viridian Therapeutics?
Viridian Therapeutics is owned by institutional shareholders (113.75%), insiders (0.01%), and public (-13.75%). The largest institutional shareholder of Viridian Therapeutics is FMR LLC (15.67% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.54% of total shares).
Who are the major institutional shareholders of Viridian Therapeutics?
Viridian Therapeutics's major institutional shareholders are FMR LLC, BLACKROCK INC., DEEP TRACK CAPITAL, LP, VR ADVISER, LLC, and VANGUARD GROUP INC. The top five shareholders own together 41.73% of the company's share outstanding.
How many Viridian Therapeutics shareholders are there?
As of Jun 2024, there are 146 institutional shareholders of Viridian Therapeutics.
What percentage of Viridian Therapeutics is owned by FMR LLC?
FMR LLC owns 9.57M shares of Viridian Therapeutics, representing 15.67% of the company's total shares outstanding, valued at $124.55M (as of Jun 2024).
What percentage of Viridian Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 4.77M shares of Viridian Therapeutics (VRDN), compromising 7.81% of the company, valued at $62.1M.
What percentage of Viridian Therapeutics is owned by DEEP TRACK CAPITAL, LP?
DEEP TRACK CAPITAL, LP is the third largest holder of Viridian Therapeutics. The company owns 3.92M of the company's shares outstanding (worth $51.05M).